Healthcare Global Enterprises Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 7 Aug 2026

Company page: Healthcare Global Enterprises share price, financials & guidance record

Healthcare Global Enterprises Limited reported a strong Q1 FY27 with a 13% YoY revenue growth to ₹695.1 crores and a 20% YoY adjusted EBITDA increase to ₹133.9 crores, driven by higher patient volumes and an improved payor mix. The newly commissioned North Bangalore hospital showed a promising start, contributing ₹6.7 crores. The company remains focused on operational excellence, capacity expansion, and achieving its long-term margin targets, despite a minor top-line impact from discontinued chemo drugs.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 13.4%, net profit up 166.7% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	554	559	585	613	647 +17%	633 +13%	652 +11%	695 +13%
Expenses	451	470	480	505	524	524	527	573
EBITDA	102	88	106	108	123 +21%	110 +25%	125 +18%	122 +13%
Margin	18%	16%	18%	18%	19%	17%	19%	18%
Other income	11	6	10	8	3	-10	-18	13
Interest	36	41	44	45	44	45	43	40
Depreciation	50	57	58	58	63	61	63	70
Profit before tax	28	-3	14	12	20 −29%	-6 −100%	1 −93%	25 +108%
Tax rate	25%	-335%	50%	50%	-4%	30%	-223%	34%
Net profit	21	8	7	6	21 +0%	-8 −200%	4 −43%	16 +167%
EPS	1.22	0.47	0.50	0.32	1.09	-0.63	0.15	0.92

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls